北京时间8月2日凌晨，在WTA1000多伦多站资格赛中，郑钦文以3比6、4比6完败于泰国选手塔拉鲁迪，遭遇本赛季第六次“一轮游”。    CVS Health is planning to remove one type of a common decongestant from shelves after an advisory committee to the U.S. Food and Drug Administration said it was ineffective earlier this year.The products contain the oral formulation of phenylephrine (PE), which is found in several over-the-counter (OTC) medications.Although PE has been used as a decongestant for nearly a century, experts have been questioning its efficacy for years.The FDA Nonprescription Drugs Advisory Committee unanimously voted in September that PE did not improve nasal congestion any more than a placebo at the dosage given for OTC use.In response, CVS said it is removing products, in which PE is the only active ingredient from store shelves. This means products like Dayquil, which used a combination of active ingredients, will remain available for purchase."We are aware of the FDA Advisory Committee's position on oral phenylephrine (PE) and will follow direction from the FDA to ensure products we sell comply with all laws and regulations," CVS Health said in a statement. "We are removing certain oral cough and cold products that contain phenylephrine as the only active ingredient from CVS Pharmacy stores. Other oral cough and cold products will continue to be offered to meet consumer needs."CVS did not give specifies on brands that will be removed.The FDA told ABC News it has not yet determined whether it no longer considers PE to be a safe and effective medication and has not ordered the product to be removed from shelves. CVS's move is voluntary."The FDA has no further information to provide at this time regarding the timing of any decision the agency may make following the advisory committee meeting," the federal health agency said.The Consumer Healthcare Products Association told ABC News that the advisory committee's recommendation is a non-binding decision and not a change in regulation."FDA is currently in the process of reviewing the regulatory status of oral phenylephrine (PE) following September's advisory committee meeting," CHPA said in a statement. "Until FDA makes a determination on the committee's recommendation, oral PE remains a Category 1 OTC ingredient, which is generally recognized as safe and effective."Concerns were first raised about PE in 2007. Since then, evidence has accumulated showing that the drug offers little to no relief for nasal congestion.Experts believe this is because the body processes the drug before it reaches the nasal passages where it needs to work.It's unclear if other major retail pharmacy chains will follow in CVS's footsteps.Walgreens Boots Alliance would not disclose whether it was planning to remove products with PE from store shelves and said it would defer to the FDA."Walgreens follows FDA regulations. We are closely monitoring the situation and actively partnering with the Walgreens Office of Clinical Integrity and suppliers on appropriate next steps," a Walgreens spokesperson told ABC News.Other major pharmacy chains including Albertsons, Costco and Kroger did immediately reply to ABC News' request for comment. Walmart did not have an answer immediately available.ABC News' Sasha Pezenik and Sony Salzman contributed to this report.。上一次她止步资格赛还要追溯到2021年的斯特拉斯堡站。

B | 赛前，因车祸休养数月的功勋教练里巴重回场边，师徒二人过去一周在多伦多封闭训练中重点打磨发球落点与关键分处理——恰恰是本场输球的两个命门。这样的结果，比输球本身更令人担忧。因多人退赛，现世界排名第123位的郑钦文压哨递补进入多伦多站资格赛，且只赢一场就能跻身正赛。多伦多之旅也被外界认为是其提升世界排名的良机。不过，资格赛的对手塔拉鲁迪绝非泛泛之辈。这位身高仅1米71的22岁球员是资格赛2号种子、泰国头号女单，有着扎实的底线相持和极低的非受迫性失误，今年上升势头极为凶猛，本赛季已斩获38胜15负，手握伊斯坦布尔和奥斯汀两座WTA125冠军，温网闯入第二轮，现世界排名第78位。面对这样一位状态正佳的对手，郑钦文本应以稳定的发球建立优势、以多变的进攻撕开防线——但全场46%的一发进球率、零破发点的尴尬数据，恰恰说明她最锋利的武器全部哑火。第一盘第6局被破，第二盘第5局双误送出发球局，两盘走势惊人相似：僵持、被破、无力回破。

C | 全场接一发仅得2分，意味着在对手的发球局她几乎无法构成威胁。当赖以生存的进攻体系全面失灵时，比赛便成了一场慢性失血的消耗战。郑钦文赖以成名的，是一套“高风险、高回报”的进攻哲学——以暴力发球开路，以极限落点施压，用摧枯拉朽的攻势压制对手。这套打法曾帮她闯入大满贯决赛、拿下奥运金牌、跻身世界前四。但问题在于，这套体系的容错空间极小，需要力量、步伐、手感三者精密咬合。

D | 华盛顿站她轰出14记ACE和35个制胜分，却也送出46个非受迫性失误；到了多伦多，发球这一根基一旦松动，后续的战术链条便全面断裂。更致命的是，当这套“A计划”失效时，她缺少行之有效的B计划——既无法通过安全球过渡寻找机会，也缺乏切削变化打乱对手节奏。全场面对对手稳定的底线回球，她始终未能找到破局之策。比技术更难以弥合的，是心态上的裂痕。赛季初她多次承认“比赛心态急躁，总想依靠两三拍进攻终结对手”，急躁导致失误，失误加剧急躁，恶性循环。到了华盛顿站，她又说“整场比赛都很平静”——但平静的结果是“没能再多逼自己一把”。从急躁到平静过头，看似两极，实则如同一枚硬币的两面，她正在失去对关键分的掌控感。输掉这场资格赛后她直言：“现阶段我的赛场状态和心气都存在很大问题。

E | ”“心气没了”——这句话比任何技术统计都刺眼。排名从世界第4跌至第123位，法网、温网接连一轮游，本赛季6次“一场出局”——每一场失利都在加重心理负担。当一位以进攻见长的球员在场上失去侵略性，失去敢赢的决心，技术上的调整便无从谈起。里巴回来了，这当然重要。但这场失利清晰地表明：郑钦文的困境，不是换一个人站在场边就能解决的。她需要重新审视那套曾带给她一切、如今却成为枷锁的打法，更需要找到一种方式——在急躁与平静之间，重新锚定自己的内心。从巅峰到谷底，这条路她走过了。如何走回来，才是真正的考验。